Redeye provides a comment on the result of the rights issue.
Redeye is encouraged to learn that Devyser has been awarded a tender from Héma-Québec in Québec, Can...
FDA decision expected in Q3, potential sales start in Q4 DiviTum shown complimentary to ctDNA Q4’21/...
Redeye comments on Evolution’s acquisition of Nolimit City which is a small acquisition that expands...
CombiGene fortsätter att utvecklingen av CG01 i samarbete med Spark Therapeutics.
Redeye endorses the news that SenzaGen has received its largest order so far with a value of SEK 4.
Redeye states that the initial decision of IPR was negative for Neonode.
Mangold tar upp PExA till bevakning med rekommendationen Köp och en riktkurs på 1,40 kronor.
Redeye is encouraged by Azelio's progress in its most important key market.
Redeye initiates coverage of Surgical Science, a serial acquirer sporting healthy organic growth pro...
Mackmyra Svensk Whisky AB (”Mackmyra” eller ”Bolaget”) grundades år 1999 och är Sveriges första malt...
En investering i grön omställning och en lösning på energikrisen i Europa Midsummer är en investerin...
Acquiring German IT services company sepago Adds 7% to 2023e EBITA with 10% margin (est.
Shortcut Media Group (“SMG”) har under de senaste sju dagarna presenterat två LOI-avtal, varav den s...
Analyst Group har med Spherio Group ingått avtal om kontinuerlig analysbevakning, innefattande bl.
Redeye provides a comment regarding (1) the acquisitions announced in June 2022 and (2) the public t...
Q2 report due Tuesday, 19 July High estimate uncertainty going into ‘23e… …but we find several reass...
OrderYOYO announced on Friday, June 17th, that the company is joining forces with app smart GmbH (“a...
Scandion Oncology is a Danish biotechnology company that specialises in developing drugs to reverse ...
Bolaget har erhållit etableringsstöd som avser fabriken i Bari.
